Cipher Pharmaceuticals' CEO is Craig Mull, appointed in Jul 2019, has a tenure of 7.33 years. directly owns 3.9% of the company’s shares, worth $11.84M. The average tenure of the management team and the board of directors is 3.2 years and 3.1 years respectively.
Key information
Craig Mull
Chief executive officer
US$763.6k
Total compensation
CEO salary percentage
n/a
CEO tenure
7yrs
CEO ownership
3.9%
Management average tenure
3.2yrs
Board average tenure
3.1yrs
Recent management updates
Recent updates
CEO
Craig Mull
7yrs
Tenure
US$763,644
Compensation
Mr. Craig J. Mull has been Chairman of the Board of Directors at Cipher Pharmaceuticals Inc. since June 11, 2019 and serves as its Interim Chief Executive Officer since July 29, 2019, served as its Preside...
Leadership Team
Name
Position
Tenure
Compensation
Ownership
Craig Mull
Interim CEO & Chairman of the Board
7yrs
US$763.64k
3.9% $ 11.8m
Bryan Jacobs
President
1.9yrs
US$599.69k
0.036% $ 108.7k
Ryan Mailling
Chief Financial Officer
1.9yrs
US$223.46k
no data
Emilio Presti
Director of Sales & Marketing
4.5yrs
no data
no data
Shengnan Guo
Corporate Controller
no data
no data
no data
3.2yrs
Average Tenure
Experienced Management: CPHR.F's management team is considered experienced (3.2 years average tenure).
Board Members
Name
Position
Tenure
Compensation
Ownership
Craig Mull
Interim CEO & Chairman of the Board
7.3yrs
US$763.64k
3.9% $ 11.8m
Douglas Deeth
Independent Director
3.1yrs
US$125.55k
0.011% $ 32.2k
Hubert Walinski
Lead Independent Director
3.1yrs
US$122.82k
0.011% $ 32.2k
3.1yrs
Average Tenure
Experienced Board: CPHR.F's board of directors are considered experienced (3.1 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/10 06:13
End of Day Share Price
2026/07/10 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Cipher Pharmaceuticals Inc. is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.